Chen B, Liu H K, Wang H
Division of Joint Surgery and Sports Medicine, Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China.
Department of Pain, The Eighth Affiliated Hospital of Sun Yat sen University, Shenzhen, Guangdong Province, China.
Front Surg. 2022 Apr 21;9:860300. doi: 10.3389/fsurg.2022.860300. eCollection 2022.
This study aimed to evaluate the effect of arthroscopic treatment of popliteus tendinitis via an auxiliary extreme lateral approach and to investigate the pathogenesis and treatment of popliteus tendinitis.
From 2016 to 2020, arthroscopic popliteus tendon ablation was performed in 15 patients (15 knees) with popliteus tendinitis via an auxiliary extreme lateral approach. Clinical outcomes were assessed using the Lysholm knee scoring scale, the Tegner score, the International Knee Documentation Committee (IKDC) score and the visual analogue scale (VAS) pain score at the 24-month follow-up after surgery.
A total of 15 patients (mean age, 51.1 ± 7.1 years) were included. They had a mean body mass index of 23.8 ± 2.1 kg/m. The minimum follow-up period was 24 months. Comparing the postoperative state to the preoperative state, the mean postoperative Lysholm score, Tegner score, and IKDC score improved significantly from 70.0 ± 5.0, 3.0 ± 0.9, and 62.3 ± 5.5 to 89.3 ± 4.2, 4.6 ± 0.61, and 80.5 ± 4.4, respectively ( < 0.01). The preoperative VAS score for pain improved from 6.4 ± 0.5 to 0.9 ± 0.4 ( < 0.01). No patients were lost to follow-up.
Following arthroscopic-assisted treatment, all the patients with popliteus tendinitis achieved satisfactory clinical outcomes in terms of pain relief and improved function.
Level IV.
本研究旨在评估经辅助极外侧入路关节镜治疗腘肌腱炎的效果,并探讨腘肌腱炎的发病机制及治疗方法。
2016年至2020年,采用辅助极外侧入路对15例(15膝)腘肌腱炎患者进行关节镜下腘肌腱切除术。术后24个月随访时,采用Lysholm膝关节评分量表、Tegner评分、国际膝关节文献委员会(IKDC)评分和视觉模拟量表(VAS)疼痛评分评估临床疗效。
共纳入15例患者(平均年龄51.1±7.1岁)。他们的平均体重指数为23.8±2.1kg/m²。最短随访期为24个月。与术前状态相比,术后平均Lysholm评分、Tegner评分和IKDC评分分别从70.0±5.0、3.0±0.9和62.3±5.5显著提高至89.3±4.2、4.6±0.61和80.5±4.4(P<0.01)。术前VAS疼痛评分从6.4±0.5改善至0.9±0.4(P<0.01)。无患者失访。
关节镜辅助治疗后,所有腘肌腱炎患者在疼痛缓解和功能改善方面均取得了满意的临床疗效。
四级。